arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BIO-RAD LABORATORIES, INC.

BIO
$368.42 ▼ -11.58 (-3.05%) at close
Industrials ·Laboratory Analytical Instruments ·USLaboratory Analytical Instruments
72 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

BIO-RAD LABORATORIES, INC. shows strong fundamentals with top-quartile Profit Margin (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $9.9B
Dividend Yield —
Revenue Growth -0.1% ↘
Op. Margin 11.2% ↗
ROIC 0.6% ↗
FCF / Share $2.49 ↘
Trailing P/E 26.5x
Price / Book 1.4x
FCF Yield 0.7%
Debt / Equity 0.17
info Valuation on last close. End-of-day price, Nov 5, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$651.00M
— -0.1% —
Net Income Profit after all expenses
$-527.10M
— 0.0% —
Operating Margin Operating profit as % of sales
11.2%
↑ +93.6% 33th
FCF / Share Free cash flow per share
$2.49
↓ -13.9% —
Long-Term Debt Long-term obligations
$1.20B
— 0.0% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
65
Returns ↓
68
Financial Health ↓
65
Cash Quality ↑
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 19 years · 72 quarters